Module Tutor Photo
School of Life Sciences  
 
 
LSC-30018 Biochemistry and Therapy of Disease  
Co-ordinator:      
Teaching Team:  
Lecture Time: See Timetable...  
Level: 3 Credits: 15 Study Hours: 150  
School Office: Tel: 01782 734414
 
 
 
Programme/Approved Electives for

Biochemistry Major (Level 3)
Biochemistry Minor (Level 3)
Medicinal Chemistry Major (Level 3)

Available as a Free Standing Elective

No

Prerequisites

A-level Chemistry or equivalent.

Barred Combinations

None

Description

This module is intended to describe and promote understanding of the
molecular basis of therapeutic intervention in a range of diseases,
including bacterial, neurodegenerative, parasitic and neoplastic
pathologies. It will also address the questions arising from the failure of
disease therapies and describe the molecular events underlying
resistance to therapy.

2 lectures

Aims

To describe systematically and promote understanding of the molecular basis of therapeutic intervention in a range of diseases, including bacterial, neurodegenerative, parasitic and neoplastic pathologies.

To address critically the questions arising from failure of disease therapies and to describe the molecular events underlying resistance to therapy.

Intended Learning Outcomes

Upon successfull completion of the module, students will be able to:

1. Describe the relevant biochemical differences between important bacteria and the factors that lead to infection.
2. Represent the biomolecules and biochemical pathways that may be targeted by antiobiotics.
3. Describe and explain the various mechanisms by which a variety of antiobiotic drugs act to kill organisms.
4. Exaplain the need for more powerful antiobiotics and identify the challenges posed by resistant bacterial strains.
5. Be aware of the in vitro and in vivo experimental approaches to study drug resistance in eukaryotic pathogens and tumours.
6. Understand the biochemistry behind the major drug resistance pathways and discuss the potential of genomics, proteomics and combinatorial approaches for the production and screening of novel therapeutic compounds for antibiotics, eukaryotic pathogens and tumours.
7. Describe the therapeutic strategies used to combat neurodegenerative diseases.
8. Describe the ways in which recombinant DNA technology is being used in new approaches to disease therapy.
9. Abstract key information from a research paper published in an academic journal and write critically on the topic.

Study hours

Lectures - 20 hours
Coursework - 30 hours
Private study and revision - 100 hours

Description of Module Assessment

Examination: one 2 hour unseen written examination: weighting 80%
Coursework: each student will be assigned a paper from the primary literature relating to topics covered in the module; they must summarise the paper (300 words), locate and summarise five other relevant articles (100 words each) and explain their choices (200 words): weighting 20%

1: Literature Review weighted 20%
LITERATURE REVIEW


2: 2 Hour Unseen Exam weighted 80%
UNSEEN EXAM - 2 HOURS



Version: (1.06B) Updated: 02/Oct/2013

This document is the definitive current source of information about this module and supersedes any other information.